This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Nordic Congress
Connecting Nordic & Baltic Innovators With Capital
8th–9th October 2024Bella Center, Copenhagen, Denmark

Nanna Lüneborg
Partner at Novo Ventures


Nanna Lüneborg is a Partner with Novo Ventures, a leading life science firm with offices in Copenhagen, London, Boston and San Francisco, and part of Novo Holdings. She joined Novo Holdings in 2012. Previously, she was an associate at Apposite Capital, a London-based venture fund. Dr. Lüneborg holds a first-class B.A. in Physiology and Psychology from the University of Oxford, a M.B.A. with distinction from University of Cambridge, where she was a Sainsbury Scholar, and a Ph.D. in Neuroscience from University College London, where she was as a Wellcome Trust Scholar. She has worked with numerous portfolio companies from company creation through multiple venture rounds and IPOs, including Orphazyme, ObsEva, IO Biotech and Galecto. She currently serves on the boards of ReViral, Stargazer and E3 Bio.